Hostname: page-component-848d4c4894-cjp7w Total loading time: 0 Render date: 2024-06-30T03:11:22.897Z Has data issue: false hasContentIssue false

Progressive Neurological Decline Associated With Intracranial Calcification in Down Syndrome; Fahr Disease Mimic?

Published online by Cambridge University Press:  07 November 2023

Montaha Almudhry
Affiliation:
London Health Sciences Centre and Western University, London, ON, Canada Department of Neuroscience, King Fahad Specialist Hospital, Dammam, Saudi Arabia
Chitra Prasad
Affiliation:
London Health Sciences Centre and Western University, London, ON, Canada Department of Pediatrics, Western University, London, ON, Canada
KengYow Tay
Affiliation:
London Health Sciences Centre and Western University, London, ON, Canada Department of Medical Imaging, Western University, London, ON, Canada
Derek B. Debicki
Affiliation:
London Health Sciences Centre and Western University, London, ON, Canada Department of Clinical Neurological Sciences, Western University, London, ON, Canada
Asuri N. Prasad*
Affiliation:
London Health Sciences Centre and Western University, London, ON, Canada Department of Pediatrics, Western University, London, ON, Canada Department of Clinical Neurological Sciences, Western University, London, ON, Canada
*
Corresponding author: A. N. Prasad; Email: narayan.prasad@lhsc.on.ca
Rights & Permissions [Opens in a new window]

Abstract

Type
Neuroimaging Highlight
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Intracranial calcification (ICC) has been described commonly in association with congenital infections, head trauma, and endocrine or systemic metabolic derangements. However, it is also noted in patients with pathogenic genetic mutations and defects in inborn error of metabolism. Reference Livingston, Stivaros, Van Der Knaap and Crow1Reference Eskandary, Sabba, Khajehpour and Eskandari4 We report the clinical, imaging, and genetic findings in an adult with Down syndrome (DS) referred to the clinic for further investigation for Fahr disease.

A 43-year-old lady with DS, secondary to Robertsonian translocation of chromosomes 13 and 21 and a background history of hypothyroidism who remained highly functional till the age of 38 years, was noted to have progressive neurological decline affecting cognitive, motor, visual, adaptive, and linguistic abilities. At baseline, the patient had a grade 1 level in literacy and writing and was working in a nursing home with minimal supervision. However, over the span of 5 years, she progressively lost executive function, short-term recall, expressive communication, and ambulation capabilities. She also started experiencing epileptic seizures, which were controlled following the introduction of antiseizure medication, levetiracetam, and lacosamide. The patient was adopted at two years of life, details of the family history could not be elicited. A limited examination in the clinic demonstrated no eye contact; she would not interact with the examiner. She was sitting in her wheelchair, and bilateral spasticity was pronounced in the lower extremities with diffuse brisk deep tendon reflexes, however, ankle clonus was not elicited. The patient was rated by her sister for the Dementia Questionnaire for Persons with Mental Retardation Reference Prasher5 and found to score 30/66, within the range of moderate cognitive difficulties as well as moderately severe behavioral symptoms.

A CT scan requested by her neurologist as part of her investigative work up for neurological decline demonstrated calcifications within the basal ganglia, dentate nuclei, and parasagittal occipital sulci bilaterally (Figs. 1 and 2). The patient has since undergone biochemical testing, showing intact parathyroid and thyroid function; PTH:2.7 pmol/L (1.6–6.9), calcium:2.26 mmol/L (2.15–2.60), phosphorus:0.98 mmol/L (0.80–1.45), TSH:1.090mIU/L (0.465–4.680). Her karyotype was reported as 46, XX, der (13;21) (q10;q10),+21, consistent with Robertsonian translocation, between the long arms of one copy of each of chromosomes 13 and 21. Molecular genetic testing for Fahr disease was conducted with no pathogenic variant identified.

Figure 1: Axial CT illustrates dense calcification of the bilateral lentiform nuclei (white arrowheads) and bilateral parasagittal occipital cortices (thin white arrows).

Figure 2: Coronal CT shows dense calcification of the bilateral cerebellar white matter including the dentate nuclei (thick white arrows).

Patients with DS have a higher prevalence of basal ganglia calcifications with a frequency of 10%–26.2% compared to only 0.3%–0.6% in the general population. Reference Eskandary, Sabba, Khajehpour and Eskandari4,Reference Ieshima, Kisa, Yoshino, Takashima and Takeshita6,Reference Le Becker7 On scans, globus pallidus and, less commonly, the head of the caudate are the most affected structures, while other areas like the choroid plexus and pineal body are found to be just as frequently calcified in healthy individuals. Reference Ieshima, Kisa, Yoshino, Takashima and Takeshita6 Histopathology reveals that the calcification involves the media of small arteries in the perivascular regions and amyloid degeneration. Reference Le Becker7 The exact underlying pathogenesis of calcium deposit in DS remains to be elucidated. Clinically, the identification of ICC has been linked to accelerated aging and premature onset of dementia in DS. Reference Wisniewski, French, Rosen, Kozlowski, Tenner and Wisniewski8

Imaging studies (Figs. 1 and 2) in this individual confirm that the intracranial calcification extends beyond the basal ganglia to the cerebellum’s dentate nuclei, providing additional justification for molecular testing for Fahr disease. Being aware of this phenomenon in DS could help with early diagnosis and prevent unneeded, costly, and time-consuming investigations.

Funding

None.

Competing interests

One of the authors ANP has received payment from the Canadian Medical Protection Association for expert opinion in a medicolegal case that is unrelated to the material or case in the submitted manuscript. A second author, DD, also received payment as a speaker’s honorarium at UBC Canada that is unrelated to this manuscript.

Statement of authorship

MA wrote the manuscript; KT reviewed the CT of the patient and provided labeled figures; and CP, ANP, and DD provided consultation and diagnosis for the patient and supervised the manuscript.

References

Livingston, JH, Stivaros, S, Van Der Knaap, MS, Crow, YJ. Recognizable phenotypes associated with intracranial calcification. Dev Med Child Neurol. 2013;55:4657.CrossRefGoogle ScholarPubMed
Livingston, JH, Stivaros, S, Warren, D, Crow, YJ. Intracranial calcification in childhood: a review of aetiologies and recognizable phenotypes. Dev Med Child Neurol. 2014;56:612–26.CrossRefGoogle ScholarPubMed
Donzuso, G, Mostile, G, Nicoletti, A, Zappia, M. Basal ganglia calcifications (Fahr’s syndrome): related conditions and clinical features. Neurol Sci. 2019;40:2251–63.CrossRefGoogle ScholarPubMed
Eskandary, H, Sabba, M, Khajehpour, F, Eskandari, M. Incidental findings in brain computed tomography scans of 3000 head trauma patients. Surg Neurol. 2005;63:550–3.CrossRefGoogle ScholarPubMed
Prasher, VP. Dementia questionnaire for persons with mental retardation (DMR): modified criteria for adults with Down’s syndrome. J Appl Res Intellect Disabil. 1997;10:5460.CrossRefGoogle Scholar
Ieshima, A, Kisa, T, Yoshino, K, Takashima, S, Takeshita, K. A morphometric CT study of down’s syndrome showing small posterior fossa and calcification of basal ganglia. Neuroradiology. 1984;26:493–8.CrossRefGoogle ScholarPubMed
Le Becker, S. Basal ganglia calcification in Down’s syndrome. J Neurol Neurosurg Psychiatry. 1985;48:61–4.Google Scholar
Wisniewski, KE, French, JH, Rosen, JF, Kozlowski, PB, Tenner, M, Wisniewski, HM. Basal ganglia calcification (BGC) in Down’s syndrome (DS)--another manifestation of premature aging. Ann N Y Acad Sci. 1982;396:179–89.CrossRefGoogle ScholarPubMed
Figure 0

Figure 1: Axial CT illustrates dense calcification of the bilateral lentiform nuclei (white arrowheads) and bilateral parasagittal occipital cortices (thin white arrows).

Figure 1

Figure 2: Coronal CT shows dense calcification of the bilateral cerebellar white matter including the dentate nuclei (thick white arrows).